Medical Technology Company

 

We are experienced professionals in the medical trade that invest in, innovate on and develop disruptive medical technologies for strategic transfers to larger firms that can more efficiently commercialize at scale. 

The financial investors behind the firm are private and marquis. 

The operational team is led by technology transfer and IP licensing specialists with decades of expertise in the field, having excelled at successfully setting up, replicating and operating multiple manufacturing plants across the globe associated with technology leaders like Motorola, Nasdaq listed Citrix Systems (NQ: CTXS), Florida based Boca Research and renowned medical technology firm CCC del Uruguay. 

Current investments focus around platform technologies for active implantable medical device (AIMD) systems. One of our prized investments are the assets acquired and further developed to disrupt the large $14B+ Cardiac Rhythm Management (CRM) and burgeon Neuromodulation industry verticals. 

CRM ‘Product Technology’ Assets

Through transfer of technology protocol with CCC the firm setup independent manufacturing operations in 2007 in Bangalore, India. Through this technology over 40,000 implantable cardiac pacemaker systems have been produced and distributed over the past three decades across Latin America, The Indian sub-continent, Asia, The GCC and MENA region, Greek & Balkan States, Eastern Europe and other such CE accepting nations. The CRM product line is high quality, affordable and well positioned to be the ‘value segment’ leader for the emerging markets. 

Per WHO Cardiac Arrhythmia is the #1 single largest therapeutic area which remains undeserved across emerging markets. The disruptive Cardiac Rhythm Management (CRM) technology developed efficiently detects and treats cardiac arrhythmia. 

The products meet the highest industry standard’s of Quality and Regulatory approvals – the products are CE Certified by BSI and the Quality Systems are ISO 13485-9001 Compliant and Certified to Class III Standards. The system complies with FDA Standards for both export only and domestic distribution. 

Neuromodulation ‘Process Technology’ Assets

The South American technology provider CCC del Uruguay [Now part of Integer Medical] holds the Gold Standard in the Intellectual Properties (IP) for the design, development , production and testing of pacemaker systems commonly used across CRM and Neuromodulation applications. These Intellectual Property assets along with the custom fabricated capital equipment required to fabricate and validate the systems were acquired by Medived. 

The firm today has unrestricted global rights to further empower established medical design, development and manufacturing companies with design and box-build capability for stimulation based CRM and Neuromodulation applications. 

Medived setup (small) R&D operations in the west-coast of North America and remains open to strategic and licensing partnership(s) to further scale the established technologies. 

Medived’s turnkey solution optimizes manpower, lowers operating cost, improves productivity and ROI. For neuromodulation companies we can offer turnkey solutions with fixed cost & timelines.

Relevant parties may establish contact at: admin@medived.com

 

Video On Pacemaker Production 

 

The link showcases a virtual tour of the AIMD manufacturing plant – setup under Technology Transfer protocol – for CRM applications.